SGLT2 Inhibitor
SGLT2 inhibitors are a class of medications that lower blood sugar by preventing the kidneys from reabsorbing glucose, leading to its excretion in urine. They are primarily used to manage type 2 diabetes but have shown potential benefits for cardiovascular health and weight management, making them relevant for longevity and health optimization.
Member access required
Clinical protocols and outcomes data are available to AXIFI Members and Providers.